Andrew Huberman, professor of neurobiology and ophthalmology at Stanford School of Medicine, explores the biological mechanisms underlying different types of aggression in this Huberman Lab Essentials episode.

The discussion covers reactive versus proactive aggression, the neural circuits involved, and the surprising role of hormones like estrogen rather than testosterone in driving aggressive behavior. Huberman explains how environmental factors like day length and stress levels modulate these biological systems.

Drawing from foundational research by Konrad Lorenz and modern neuroscience studies, the episode reveals how aggression functions as a process with distinct biological pressures that can be understood and potentially modulated through specific interventions.

The Hydraulic Pressure Model of Aggression

Konrad Lorenz, famous for studying imprinting behaviors, developed the concept that aggression operates like hydraulic pressure - multiple variables create internal pressure until behavioral expression occurs, as described in On Aggression.

Aggression is a process with beginning, middle, and end, not a single event, involving neural circuits rather than individual brain areas working in sequence.

This pressure model captures how multiple factors - hormones, neurotransmitters, childhood history, current stress - converge to create the propensity for aggressive behavior.

The Ventromedial Hypothalamus: Aggression's Command Center

Walter Hess discovered that electrical stimulation of the ventromedial hypothalamus (VMH) could instantly transform a calm cat into an aggressive state, with behavior returning to normal when stimulation stopped.

The VMH contains only about 3,000 neurons total (1,500 per brain hemisphere) but is sufficient to generate complete aggressive behavioral patterns.

David Anderson's lab at Caltech identified that specific estrogen receptor-containing neurons in the VMH are both necessary and sufficient for aggressive behavior.

Optogenetic experiments by Dayu Lin showed that activating these neurons could instantly switch a male mouse from mating behavior to attacking the female, then back to mating when stimulation stopped.

Estrogen, Not Testosterone, Drives Aggression

"Testosterone does not increase aggressiveness. Testosterone increases proactivity and the willingness to lean into effort in competitive scenarios" - Huberman.

Testosterone is converted to estrogen through aromatization by the aromatase enzyme, and it's this brain estrogen that activates VMH aggression circuits.

Mice or humans lacking the aromatase enzyme show reduced aggression despite high testosterone levels, proving estrogen's central role.

If someone is naturally benevolent, testosterone will make them more benevolent; if aggressive, it makes them more aggressive - it amplifies existing tendencies.

Environmental Modulation: Day Length and Stress

In long sunny days, estrogen does not evoke aggression, but in short days with reduced sunlight, estrogen increases aggressive propensity.

Short days increase melatonin, reduce dopamine, and elevate stress hormones like cortisol, creating conditions where estrogen triggers aggression.

High cortisol and low serotonin create the biological context that makes estrogen more likely to activate aggressive circuits in the brain.

Some people have genetic variants affecting estrogen receptor sensitivity, but day length strongly modulates whether this translates to increased aggression.

Practical Tools for Modulating Aggression

Getting sunlight in eyes early in the day and throughout the day helps maintain healthy cortisol levels and reduces aggressive tendencies.

20-minute saunas at 80-100°C or hot baths can significantly reduce cortisol levels, potentially decreasing aggressive propensity.

Ashwagandha supplementation potently decreases cortisol but should be limited to two weeks of use followed by a two-week break to avoid hormonal disruption.

Acetyl L-carnitine supplementation showed significant reductions in aggressive behavior, attentional problems, and delinquency in children with ADHD in randomized controlled trials.